Cav1/ereg/yap axis in the treatment resistance of cav1-expressing head and neck squamous cell carcinoma

HIGHLIGHTS

• who: Mickaël Burgy et al. from the Laboratory of Bioimaging and Pathology, University of Strasbourg, CNRS, Illkirch, France have published the paper: Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma, in the Journal: (JOURNAL)
• what: The authors investigated the role of Caveolin-1 (Cav1) in the sensitivity of HNSCC cell lines to CTX-radiotherapy that might predict HNSCC relapse. This study showed that the overexpression of Cav1 is associated with locoregional relapse and poor prognosis. The authors reported that Cav1 may also play a role . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.